News GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 10:17:25 12/05/2026 BST			5-day change	1st Jan Change
1,848.75 ^GBX	+0.23%		-0.38%	+1.40%

05-11	Global markets live: Alphabet, Cerebras, Compass, GSK, Rockwool…
05-11	GSK plc and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Enter Exclusive Collaboration for Bepirovirsen in China	CI

All News

Mentions Relevance

05-11	GSK plc and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Enter Exclusive Collaboration for Bepirovirsen in China	CI
05-11	GSK Teams Up with Sino Biopharmaceutical for Distribution of Potential Hepatitis B Drug in China	MT
05-11	GSK, Sino Biopharmaceutical Unit Collaborate for China Launch of Bepirovirsen	MT
05-11	GSK agrees China hepatitis B deal as kicks off last tranche of buyback	AN
05-11	Compass lifts outlook as GSK expands in China	AN
05-11	GSK Kicks Off Fifth Tranche of GBP2 Billion Share Repurchase Program	MT
05-11	GSK Signs Chronic Hepatitis B Drug's Marketing Deal With China's Sino Biopharmaceutical	MT
05-11	GSK Partners With SBP to Speed Up China Rollout of Hepatitis Drug	DJ
05-11	GSK plans to sell chronic hepatitis B drug in China through Sino Biopharm	RE
05-11	GSK enters exclusive collaboration with SBP Group to accelerate bepirovirsen launch in China	RE
05-11	GSK : enters exclusive collaboration with SBP Group, a market leader in hepatology in China, to accelerate bepirovirsen at launch	PU
05-07	Halozyme, GSK Enter Collaboration, Licensing Agreement	MT
05-07	Halozyme announces global collaboration and license agreement with GSK to develop subcutaneous formulations of multiple promising oncology targets	RE
05-07	Halozyme Announces Global Collaboration and License Agreement with GSK to Develop Subcutaneous Formulations of Multiple Promising Oncology Targets	CI
05-07	Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults	BU
05-06	GSK says all 25 resolutions passed at AGM	RE
05-06	GSK : 2026 Remuneration Policy	PU
05-06	GSK : presents latest respiratory research to advance patient care at ATS 2026	PU
05-05	US FDA blocked publication of COVID, shingles vaccine safety studies	RE
05-05	GSK : Bernstein remains its Buy rating	ZD
05-05	GSK Price Target Cut as Bernstein Notes Near-term Catalysts	MT
05-01	GSK's Linerixibat Gets UK Nod for Itch Linked to Biliary Disease	MT
05-01	UK Regulator Approves GSK's Lynavoy as Treatment for Liver Disease Itch	MT
05-01	Dodge & Cox discloses 4.93% stake in GSK as of April 28, filing says	RE
05-01	UK Regulator Clears GSK's Linerixibat for Treatment of Biliary Tract Disease-related Itch	MT